Clinical Trials Sponsored by Capgemini Invent

Total 397 results

Invent Medic Sweden AB

Completed

An Investigation With an Intra-vaginal Device for Stress Urinary Incontinence

Stress Urinary Incontinence

Sweden
Assistance Publique - Hôpitaux de Paris
Traumabase Group; Capgemini Invent; Ecole polytechnique; EHESS (Ecole des hautes... and other collaborators

Recruiting

Prospective Validation of the SHOCKMATRIX Hemorrhage Predictive Model (SHOCKMATRIX)

Wounds and Injuries | Hemorrhagic Shock | Traumatic Shock

France
Intent Solutions, Inc.

Completed

Utilization of the TAD Device for Dispensing Pain Medications in Hospice Patients

Medication Adherence | Satisfaction, Personal

United States
Fundacion Infant

Completed

Prevention of Severe Covid-19 in Infected Elderly by Early Administration of Convalescent Plasma With High-titers of Antibody Against SARS-CoV2

COVID

Argentina
Queen's University, Belfast
Invest NI

Completed

Project Daire: Derry/Londonderry as the Nexus City for Food, Education, Trust and Health (Daire)

Knowledge, Attitudes, Practice

United Kingdom
Fundacion Infant

Completed

Role of Human Milk Bank in the Protection of Severe Respiratory Disease in Very Low Birth Weight Premature Infants

Respiratory Infections

Argentina
Fundacion Infant

Completed

Clinical and Immunologic Impact of Perinatal SARS-CoV-2 (COVID-19) Infection

Covid19 | Pregnancy Related | Neonatal Infection

Argentina
Revent Medical International B.V.
Revent Medical, Inc.

Terminated

REV 002 Observational Study of the ReVENT Sleep Apnea System: Minimally Invasive Treatment for Obstructive Sleep Apnea

Obstructive Sleep Apnea

Germany, Belgium, Netherlands, Czech Republic, Switzerland
Ascension St. Vincent

Terminated

Discerning Pseudoprogression vs True Tumor Growth in GBMs

Glioblastoma
Invendo Medical GmbH

Terminated

Single Arm Post-marketing Study of SC20 Colonoscope (SC20 Scope)

Gentle Colonoscopy

United States
Incept BioSystems, Inc.

Completed

In Vitro Human Embryo Culture System

Infertility

United States
Invendo Medical GmbH

Completed

Performance Study of the Invendo C20 Colonoscope System in Colorectal Cancer Screening

Colorectal Cancer Screening

Germany
Yuinvent Innovations Ltd.

Unknown

A Non-invasive Device to Remove Fluid From the Middle Ear

Otitis Media With Effusion
Nventa Biopharmaceuticals Corporation

Unknown

Safety Study to Test the Safety of HspE7 and Poly-ICLC Given in Patients With Cervical Intraepithelial Neoplasia

Cervical Intraepithelial Neoplasia

United States
Ascension St. Vincent Carmel Hospital
St. Vincent Foundation

Completed

Promoting Physical Activity Among Bariatric Surgery Patients

Obesity

United States
Infant Bacterial Therapeutics

Active, not recruiting

IBP-9414 for the Prevention of Necrotizing Enterocolitis - The Connection Study

Necrotizing Enterocolitis

United States, Spain, Israel, United Kingdom, France, Poland, Romania, Bulgaria, Hungary, Serbia
Yuinvent Innovations Ltd.

Unknown

Safety and Efficacy of a Device for the Relief of Pain Due to Carpal Tunnel Syndrome

Carpal Tunnel Syndrome

Israel
Infant Bacterial Therapeutics

Completed

IBP-9414 for the Prevention of Necrotizing Enterocolitis

Necrotizing Enterocolitis

United States
Nventa Biopharmaceuticals Corporation

Completed

A Trial Study of SGN-00101 in Treating Pediatric Patients With Recurrent Respiratory Papillomatosis

Papilloma | Recurrent Respiratory Papillomatosis

United States
Innovent Biologics (Suzhou) Co. Ltd.
Innovent Biologics (USA), Inc.

Withdrawn

A Platform Study of Novel Immunotherapy Products in Participants With Previously Treated Unresectable or Metastatic Cutaneous Melanoma

Metastatic Cutaneous Melanoma | Unresectable Cutaneous Melanoma

United States, Germany, France, Australia, Spain, Switzerland, United Kingdom
Mount Saint Vincent University

Completed

Dairy Products With Reduced Sugar and Blood Glucose

Overweight and Obesity | Metabolic Disease | Blood Glucose, High

Canada
Mount Saint Vincent University

Completed

The Effect of Navy Beans and Yellow Peas on Satiety in Children

Eating | Satiety | Food | Physical Comfort

Canada
Vincent Duron

Not yet recruiting

Fetal Endoscopic Tracheal Occlusion (FETO) Trial for Congenital Diaphragmatic Hernia (CDH)

Diaphragmatic Hernia

United States
Mount Saint Vincent University

Completed

Effect of Processed Blueberry on Blood Glucose and Antioxidant Status in Human Adults

Blood Glucose

Canada
Mount Saint Vincent University

Completed

The Effect of Pulse Flours on Blood Glucose, Satiety and Food Intake

Blood Glucose | Eating | Food | Appetite

Canada
St. Vincent Hospital, Vienna

Completed

Changes of Bone Mineral Density in Total Hip Arthroplasty

Bone Mineral Density
Saint Vincent Hospital, Pennsylvania

Terminated

King Video Laryngoscope Versus Direct Laryngoscopy for Prehospital Intubation: A Randomized Controlled Trial

Respiratory Failure

United States
Vivent Health
Gilead Sciences

Recruiting

Telehealth as a Modality to Increase the Uptake of PrEP Services in Black and Latino: "e-PrEP" (e-PrEP)

HIV Prevention

United States
Aptinyx
inVentiv Health Clinical

Completed

Evaluate the Efficacy and Safety of NYX-2925 in Subjects With Fibromyalgia

Fibromyalgia

United States
Mount Saint Vincent University

Completed

The Effect of Buckwheat and Couscous on Satiety and Food Intake in Young Adults

Eating | Food | Appetite

Canada
Revent Medical International B.V.

Completed

Feasibility Study of the ReVENT Sleep Apnea System (REV-001)

Obstructive Sleep Apnea (OSA)
Innovent Biologics (Suzhou) Co. Ltd.

Not yet recruiting

IBI3001 in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors

Locally Advanced Solid Tumor

Australia
Algalarrondo Vincent
Bichat Hospital; Bioquantis

Recruiting

Artificial Intelligence to Assist the Echocardiographic Identification of Transthyretin Cardiac Amyloidosis (AI-ATTR-ECHO)

Transthyretin Cardiac Amyloidosis | Transthyretin Amyloid Cardiomyopathy | Amyloid Cardiomyopathy

France
Innovent Biologics (Suzhou) Co. Ltd.

Recruiting

A First-in-human, Single-ascending-dose Study of IBI3002 in Healthy Participants and Mild to Moderate Asthmatics

Asthma | Healthy Participants

Australia
Innovent Biologics (Suzhou) Co. Ltd.

Recruiting

A Study of IBI112 in Chinese Patients With Psoriasis Who Were Previously Treated With Biologics

Psoriasis

China
Innovent Biologics (Suzhou) Co. Ltd.

Recruiting

A Clinical Study of IBI130 for Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors

Solid Tumor

Australia
Innovent Biologics (Suzhou) Co. Ltd.

Not yet recruiting

The Study of Tusamitamab Ravtansine (IBI126) Combined With Sintilimab and Tusamitamab Ravtansine (IBI126) Combined With Sintilimab Plus Platinum-based Chemotherapy and Pemetrexed in Subjects With CEACAM5 Positive Expression Advanced/Metastatic Non-squamous Non-small-cell Lung Cancer (NSQ NSCLC)

Non-squamous Non-small-cell Lung Cancer

China
Innovent Biologics (Suzhou) Co. Ltd.

Not yet recruiting

A First-in-human Study of IBI354 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors

Locally Advanced Unresectable or Metastatic Solid Tumors

Australia
Innovent Biologics (Suzhou) Co. Ltd.

Recruiting

Efficacy and Safety of IBI351 in Combination With Sintilimab ± Chemotherapy in Advanced Non-squamous Non-small Cell Lung Cancer Subjects With KRAS G12C Mutation

Advanced Non-Small Cell Lung Cancer

China
Innovent Biologics (Suzhou) Co. Ltd.

Recruiting

A Study of IBI351 in Combination With Cetuximab in Subjects With KRAS G12C Mutated Metastatic Colorectal Cancer

Colorectal Cancer

China
Innovent Biologics (Suzhou) Co. Ltd.

Recruiting

A Phase 1, Open-label, Multicenter, Dose Escalation Study of IBI363 (PD1-IL2m) in Subjects With Advanced Solid Malignancies or Lymphomas

Solid Malignancies or Lymphomas

Australia
Innovent Biologics (Suzhou) Co. Ltd.

Not yet recruiting

A Phase Ib Study of Primary Efficacy and Safety of IBI321 Monotherapy or Combination Therapy in Patients With Advanced Solid Tumors

Advanced Solid Tumors

China
Innovent Biologics (Suzhou) Co. Ltd.

Recruiting

Safety and Efficacy of IBI389 Single Agent, and in Combination With Sintilimab, in Patients With Advanced Malignancies

Advanced Solid Tumors

China
Innovent Biologics (Suzhou) Co. Ltd.

Recruiting

A Study of IBI306 in Participants With Hypercholesterolemia

Hypercholesterolemia

China
Innovent Biologics (Suzhou) Co. Ltd.

Recruiting

A Study Evaluating the Safety, Tolerability, and Initial Efficacy of IBI110 in Subjects With Advanced Malignant Tumors

Advanced Malignancies

China
Innovent Biologics (Suzhou) Co. Ltd.

Completed

A Study of IBI362 in Chinese Patients With Type 2 Diabetes

Type 2 Diabetes

China
Innovent Biologics (Suzhou) Co. Ltd.

Terminated

A Safety, Tolerability, and Efficacy Study of IBI314 in Ambulatory Patients With COVID-19

COVID-19

United States
Innovent Biologics (Suzhou) Co. Ltd.

Completed

A Phase II Clinical Study to Assess the Efficacy and Safety of IBI310 or Placebo Combined With Sintilimab for Advanced Cervical Cancer Subjects Who Have Failed or Cannot Tolerate First-line or Above Platinum-based Chemotherapy

Advanced Cervical Cancer

China
Innovent Biologics (Suzhou) Co. Ltd.

Active, not recruiting

A Study of Longer Interval of IVT IBI302 in Subjects With nAMD

Neovascular Age-related Macular Degeneration

China
Innovent Biologics (Suzhou) Co. Ltd.

Completed

Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of IBI362 in Overweight or Obesity Subjects

Overweight or Obesity

China

3

Subscribe